Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Pathogens (Basel, Switzerland)
|
February 25, 2023
Screening the Pathogen Box to Discover and Characterize New Cruzain and <i>Tbr</i>CatL Inhibitors
Thales do Valle Moreira, Luan Carvalho Martins, Lucas Abreu Diniz, et al.
Molecules (Basel, Switzerland)
|
September 14, 2024
Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain
Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2025
Thiosulfonate-Based Targeted Covalent Cruzipain Inhibitors with Enhanced Bioactivity Translation for Antichagasic Therapy
Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, et al.
ACS Medicinal Chemistry Letters
|
January 15, 2025
Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain
Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, et al.
Journal of Chemical Information and Modeling
|
November 8, 2025
Structure-Based Discovery of Non-Covalent Triazole-Based Cruzipain Inhibitors with Improved Bioactivity Translation
Juan Pablo Cerutti, Juan Ignacio Estrada Canepa, Lucas Abreu Diniz, et al.
ACS Omega
|
February 9, 2026
Synthesis and Biological Evaluation of Tetrahydroisoquinoline Derivatives as Trypanocidal Agents
João Paulo de Moura Lopes, Gabriel Vitor de Lima Marques, Lucas Abreu Diniz, et al.
Memorias Do Instituto Oswaldo Cruz
|
February 12, 2025
Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease
Rahamah Sheu-Idrees, Gabriel Vitor de Lima Marques, Pedro Augusto Lemos Santana, et al.
European Journal of Medicinal Chemistry
|
July 13, 2023
Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi
Rúbia Castro Fernandes Melo Reis, Elda Gonçalves Dos Santos, Monique Dias Benedetti, et al.
European Journal of Medicinal Chemistry
|
May 5, 2026
Discovery of an efficacious 2-ethyl-4-phenylthiazole derivative against acute Chagas disease via multiparametric hit-to-lead optimization and in vivo efficacy
Thibault Joseph William Jacques Dit Lapierre, Daniela de Melo Resende, Felipe da Silva Mendonça de Melo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Pathogens (Basel, Switzerland)
|
February 25, 2023
Screening the Pathogen Box to Discover and Characterize New Cruzain and <i>Tbr</i>CatL Inhibitors
Thales do Valle Moreira, Luan Carvalho Martins, Lucas Abreu Diniz, et al.
Molecules (Basel, Switzerland)
|
September 14, 2024
Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain
Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2025
Thiosulfonate-Based Targeted Covalent Cruzipain Inhibitors with Enhanced Bioactivity Translation for Antichagasic Therapy
Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, et al.
ACS Medicinal Chemistry Letters
|
January 15, 2025
Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain
Juan Pablo Cerutti, Lucas Abreu Diniz, Viviane Corrêa Santos, et al.
Journal of Chemical Information and Modeling
|
November 8, 2025
Structure-Based Discovery of Non-Covalent Triazole-Based Cruzipain Inhibitors with Improved Bioactivity Translation
Juan Pablo Cerutti, Juan Ignacio Estrada Canepa, Lucas Abreu Diniz, et al.
ACS Omega
|
February 9, 2026
Synthesis and Biological Evaluation of Tetrahydroisoquinoline Derivatives as Trypanocidal Agents
João Paulo de Moura Lopes, Gabriel Vitor de Lima Marques, Lucas Abreu Diniz, et al.
Memorias Do Instituto Oswaldo Cruz
|
February 12, 2025
Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease
Rahamah Sheu-Idrees, Gabriel Vitor de Lima Marques, Pedro Augusto Lemos Santana, et al.
European Journal of Medicinal Chemistry
|
July 13, 2023
Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi
Rúbia Castro Fernandes Melo Reis, Elda Gonçalves Dos Santos, Monique Dias Benedetti, et al.
European Journal of Medicinal Chemistry
|
May 5, 2026
Discovery of an efficacious 2-ethyl-4-phenylthiazole derivative against acute Chagas disease via multiparametric hit-to-lead optimization and in vivo efficacy
Thibault Joseph William Jacques Dit Lapierre, Daniela de Melo Resende, Felipe da Silva Mendonça de Melo, et al.
Page
of 1